Stock Price
237.00
Daily Change
-3.30 -1.37%
Monthly
-8.39%
Yearly
49.48%
Q2 Forecast
231.88

UCB reported EUR1.29B in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Alcon AG USD 297M 16M Mar/2026
Almirall EUR 30.23M 12.8M Dec/2025
Amarin USD -2.26M 564K Dec/2025
argenx SE USD 394M 22.86M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Genmab DKK 260M 199M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
GRIFOLS EUR 249M 26.38M Mar/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Lakefront Biotherapeutics EUR -63.7M 844.26M Mar/2026
Lonza CHF 673M 243M Jun/2025
Merck EUR 474M 738M Dec/2025
Novartis USD 4.24B 171M Mar/2026
Orion EUR 114.8M 213.4M Mar/2026
Recordati EUR 278.23M 112.58M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
UCB EUR 1.29B 571M Dec/2025
Unibail Rodamco EUR 844.1M 102.4M Dec/2025